FDA-cleared profile

Bonelogic

Disior Ltd

Bonelogic 2.2 assists orthopedic healthcare professionals with diagnosis and surgical planning by semi-automatically segmenting bony structures from CT and producing foot and ankle 3D models and measurements for clinician review.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Bonelogic 2.2 assists orthopedic healthcare professionals with diagnosis and surgical planning by semi-automatically segmenting bony structures from CT and producing foot and ankle 3D models and measurements for clinician review.
FDA source Exact FDA submission Checked 2026-09-04
Intended users
Orthopedic surgeons, radiologists, and other trained healthcare professionals involved in foot and ankle diagnosis or surgical planning.
FDA source Exact FDA submission Checked 2026-09-04
Care setting and population
Hospital and clinic orthopedic or radiology workflows.
FDA source Exact FDA submission Checked 2026-09-04
Workflow role
Accepts CT images, assists or refines bone segmentation, builds 3D anatomy, and provides linear and angular measurement templates for planning.
FDA source Exact FDA submission Checked 2026-09-04
Required input
Foot and ankle CT DICOM images with user identification of laterality and acknowledgment or correction of bony structures.
FDA source Exact FDA submission Checked 2026-09-04
Output and human action
3D foot and ankle bone models, measurements, templates, and planning views; the FDA material also describes physical replication of anatomy.
FDA source Exact FDA submission Checked 2026-09-04
Limitations
Use is limited to CT foot and ankle anatomy and the supported segmentation workflow; user acknowledgment or correction and professional interpretation remain required, and the outputs are not a substitute for complete clinical evaluation.
FDA source Exact FDA submission Checked 2026-09-04

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K223757
FDA source Exact FDA submission Checked 2026-08-31
Modality
CT/CTA
FDA source Exact FDA submission Checked 2026-09-04
Anatomy
Foot/ankle
FDA source Exact FDA submission Checked 2026-09-04
Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2023-12-08
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
The FDA material describes CT DICOM input, user-assisted segmentation, 3D model generation, and measurements for display or planning.
FDA source Exact FDA submission Checked 2026-09-04

This is the interface boundary described in the exact FDA decision material; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.

Deployment and data flow
On-premise
Public source Exact FDA submission Checked 2026-08-13

Deployment category preserved from the prior exact-submission review; hosting region, data flow, and current commercial configuration still require vendor confirmation.

Security and privacy
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.

Training and support
Only Orthopedic surgeons, radiologists, and other trained healthcare professionals involved in foot and ankle diagnosis or surgical planning should operate or interpret the product; local onboarding must cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
FDA source Exact FDA submission Checked 2026-09-04
Monitoring and change control
Monitor K223757 by exact hardware, software, model, algorithm version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track these product-specific limits: Use is limited to CT foot and ankle anatomy and the supported segmentation workflow; user acknowledgment or correction and professional interpretation remain required, and the outputs are not a substitute for complete clinical evaluation.
FDA source Exact FDA submission Checked 2026-09-04

Buyer-facing monitoring guidance derived from the exact cleared scope; it is not a claim that the FDA package provides a live monitoring service.

Release and scope verification

Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K223757 before acceptance.

exact submission · checked 2026-09-04

Later product-family features are not evidence that this cleared release includes them.

Deployment boundary

The exact public deployment topology remains incomplete; establish hosting responsibility, data flow, availability, upgrade, service, and downtime boundaries locally.

exact submission · checked 2026-09-04

FDA-described deployment boundaries do not establish current hosting contracts, security controls, uptime, or local qualification.

Interoperability acceptance

The FDA material describes CT DICOM input, user-assisted segmentation, 3D model generation, and measurements for display or planning.

exact submission · checked 2026-09-04

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Use is limited to CT foot and ankle anatomy and the supported segmentation workflow; user acknowledgment or correction and professional interpretation remain required, and the outputs are not a substitute for complete clinical evaluation.

exact submission · checked 2026-09-04

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-04

No exact-product price was found in the reviewed public material; productivity or value claims require local evidence.

Lifecycle monitoring

Monitor K223757 by exact hardware, software, model, algorithm version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates.

exact submission · checked 2026-09-04

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
K223757 FDA material reports a clinical-data verification study of 82 CT image series with 100% correct identification of foot and ankle bones and 98.8% correct identification of metal, plus separate development cohorts; these are submission-specific segmentation endpoints.
FDA source Exact FDA submission Checked 2026-09-04
Reported sensitivity
98%
FDA source Exact FDA submission Checked 2026-08-13

Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.

Reported specificity
98.8%
FDA source Exact FDA submission Checked 2026-08-13

Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.

Foot and ankle bone identification

100 percent of image series

Correctly identified foot and ankle bones in 82 CT image series in the FDA test study.

Tested version: Bonelogic 2.2 configuration described in K223757

Metal identification

98.8 percent of image series

Correctly identified metal in 82 CT image series in the FDA test study.

Tested version: Bonelogic 2.2 configuration described in K223757

Metal identification sensitivity

100 percent

Sensitivity for metal identification in FDA metal-identification test data.

Tested version: Bonelogic 2.2 configuration described in K223757

Metal identification specificity

98 percent

Specificity for metal identification in FDA metal-identification test data.

Tested version: Bonelogic 2.2 configuration described in K223757

K223757 FDA evidence package for Bonelogic

FDA 510(k) software verification and clinical-data segmentation study against orthopedic-surgeon reference labels. · 82 test CT image series and development cohorts drawn from 357 studies representing 340 individual patients across U.S. and European sites.

exact submission · Tested version: Bonelogic 2.2 configuration described in K223757 · n=82 · Sponsor or vendor study

K223757

Three orthopedic surgeons provided ground truth; training, tuning, and test data were separated. Metrics are not product-wide diagnostic accuracy.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

Reimbursement and coding
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging or clinical service line and verify payer, site-of-service, coding, and coverage assumptions independently.
Public source Not applicable Checked 2026-09-04

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

This is not a product-specific reimbursement determination. Verify payer, site-of-service, coding, and coverage assumptions independently.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K223757 by exact native submission identifier. This does not exclude product-family, later-version, or adverse-event information.
Public source Exact FDA submission Checked 2026-09-04

Exact-identifier review does not prove absence of all product-family safety signals.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
32Fields reviewed
11Source classes checked
17Reviewed PubMed leads
1Reviewed trial leads
0Unreviewed FDA recall leads

Screened 17 PubMed and one ClinicalTrials.gov record. Bonelogic mentions are versions 1.0, 2.0, 2.1, CMF, developer-level, or unstated rather than the K223757 Bonelogic 2.2 configuration; all 18 were quarantined and none was promoted. The current discovery snapshot contains 17 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-04.

Alternatives

Related tools to compare

FDA-cleared K221432

Customize

3D-Side SA

Customize supports adult total ankle arthroplasty planning with CT segmentation, three-dimensional models, implant positioning and sizing, treatment-plan review, and...

Modality
CT/CTA
Anatomy
Foot/Ankle
Decision
2022-08-03
FDA-cleared K240642

SMART Bun-Yo-Matic CT

Disior Ltd

SMART Bun-Yo-Matic CT analyzes CT images of the foot and ankle to provide three-dimensional visualizations, measurements, and surgical-planning information for orthopaedic care.

Modality
CT/CTA
Anatomy
Foot/Ankle
Decision
2024-06-20